Trupanion's Q3 Net Income Soars 312% on Strong Revenue Growth

Ticker: TRUP · Form: 10-Q · Filed: 2025-11-06T00:00:00.000Z

Sentiment: bullish

Topics: Pet Insurance, Financial Results, Revenue Growth, Profitability, Earnings Per Share, Operating Income, Balance Sheet

Related Tickers: TRUP, PETS, WOOF

TL;DR

**TRUP is finally turning the corner on profitability, making it a strong buy as pet ownership continues to boom.**

AI Summary

Trupanion, Inc. reported a significant increase in net income for the three and nine months ended September 30, 2025. For the three months, net income surged to $5.873 million from $1.425 million in the prior year, a 312% increase. Revenue also grew, reaching $366.920 million for the quarter, up from $327.456 million in 2024, representing a 12.06% increase. For the nine-month period, the company swung to a net income of $13.803 million from a net loss of $11.289 million in the same period of 2024. Total revenue for the nine months increased by 12.03% to $1.062 billion from $948.377 million. Key business changes include increased investment in technology and development, up 24.6% to $9.887 million for the quarter, and a 19.87% rise in new pet acquisition expense to $21.946 million, indicating continued growth efforts. The company's balance sheet shows total assets growing to $880.173 million from $806.853 million at December 31, 2024, driven by increases in short-term investments and accounts receivable. Strategic outlook appears focused on continued expansion and operational efficiency, as evidenced by the improved profitability despite increased operating expenses.

Why It Matters

This strong performance signals Trupanion's ability to scale its pet insurance business profitably, which is crucial for investors in a competitive market. The significant increase in net income and revenue demonstrates effective execution of its growth strategy, potentially attracting more institutional investment. For employees, this financial health could mean job security and opportunities for growth within a thriving company. Customers benefit from a stable and expanding service provider, ensuring continued access to pet insurance. In the broader market, Trupanion's success could intensify competition in the pet insurance sector, potentially leading to innovation and better offerings across the industry.

Risk Assessment

Risk Level: medium — While net income is up significantly, the company's operating expenses, particularly 'new pet acquisition expense' at $21.946 million for the quarter, continue to be substantial. The 'reserve for veterinary invoices' also increased to $53.972 million from $51.635 million, indicating ongoing claims liabilities. The company also carries long-term debt of $113.790 million, which, while decreasing, still represents a financial obligation.

Analyst Insight

Investors should consider initiating or increasing positions in TRUP, given the strong swing to profitability and consistent revenue growth. Monitor the efficiency of new pet acquisition expenses and the management of veterinary invoice reserves, as these are key to sustained profitability.

Financial Highlights

revenue
$1.062B
operating Margin
0.63%
total Assets
$880.173M
total Debt
$113.790M
net Income
$13.803M
eps
$0.32
gross Margin
17.58%
cash Position
$154.773M
revenue Growth
+12.03%

Revenue Breakdown

SegmentRevenueGrowth
Total Revenue$1.062B+12.03%

Key Numbers

Key Players & Entities

FAQ

What were Trupanion's net income and revenue for the three months ended September 30, 2025?

Trupanion, Inc. reported a net income of $5.873 million for the three months ended September 30, 2025, a significant increase from $1.425 million in the same period of 2024. Revenue for the quarter reached $366.920 million, up from $327.456 million in the prior year.

How did Trupanion's year-to-date financial performance compare to the previous year?

For the nine months ended September 30, 2025, Trupanion achieved a net income of $13.803 million, a substantial improvement from a net loss of $11.289 million in the same period of 2024. Total revenue for this period increased by 12.03% to $1.062 billion from $948.377 million.

What were the key drivers of Trupanion's increased operating expenses?

Key drivers of increased operating expenses for Trupanion included a 24.6% rise in technology and development expenses to $9.887 million for the three months ended September 30, 2025, and a 19.87% increase in new pet acquisition expense to $21.946 million for the same period.

What is Trupanion's current cash and investment position?

As of September 30, 2025, Trupanion had cash and cash equivalents of $154.773 million and short-term investments totaling $193.761 million. This represents a slight decrease in cash and cash equivalents from $160.295 million at December 31, 2024, but an increase in short-term investments from $147.089 million.

How has Trupanion's debt changed over the past nine months?

Trupanion's long-term debt decreased to $113.790 million as of September 30, 2025, from $127.537 million at December 31, 2024. The current portion of long-term debt also decreased to $750 thousand from $1.350 million.

What is the basic and diluted earnings per share for Trupanion?

For the three months ended September 30, 2025, Trupanion reported basic earnings per share of $0.14 and diluted earnings per share of $0.13. For the nine months ended September 30, 2025, both basic and diluted earnings per share were $0.32.

What are the primary risks Trupanion highlights in its filing?

Trupanion highlights that forward-looking statements are subject to risks, uncertainties, and assumptions, including those discussed in its Annual Report on Form 10-K for the fiscal year ended December 31, 2024. The company operates in a very competitive and rapidly changing environment, with new risks emerging over time.

What new accounting pronouncements might impact Trupanion?

Trupanion is evaluating the impact of ASU 2023-09 (income tax disclosures, effective after December 15, 2024), ASU 2024-03 (expense category disclosures, effective after December 15, 2026), and ASU 2025-06 (software costs, effective after December 15, 2027).

How many shares of common stock does Trupanion have outstanding?

As of October 30, 2025, Trupanion had approximately 43,198,164 shares of its common stock outstanding. The weighted average shares of common stock outstanding for diluted EPS for the three months ended September 30, 2025, was 43,562,132.

What is Trupanion's business model?

Trupanion, Inc. provides medical insurance for cats and dogs in the United States, Canada, and certain countries in Continental Europe. It uses a data-driven, vertically-integrated approach to develop and offer high-value medical insurance products, priced to account for each pet's unique characteristics and coverage level.

Risk Factors

Industry Context

The pet insurance industry continues to experience robust growth, driven by increasing pet humanization and rising veterinary care costs. Trupanion operates in a competitive landscape with other established players and emerging insurtech companies. Key trends include the adoption of technology for claims processing and customer engagement, as well as a focus on preventative care and wellness plans.

Regulatory Implications

Trupanion operates under state-specific insurance regulations in the U.S. and similar frameworks internationally. Compliance with these regulations, including those related to solvency, consumer protection, and claims handling, is critical. Changes in regulatory requirements could necessitate adjustments to business practices or product offerings.

What Investors Should Do

  1. [object Object]
  2. [object Object]
  3. [object Object]
  4. [object Object]

Key Dates

Glossary

Veterinary invoice expense
The cost incurred by Trupanion to reimburse policyholders for veterinary treatments covered under their pet insurance policies. (This is the largest single expense category, directly impacting the company's gross margin and overall profitability. Its growth rate is a key indicator of underwriting performance and healthcare cost trends.)
New pet acquisition expense
Costs associated with marketing, sales, and onboarding new pet insurance policyholders. (This expense reflects the company's investment in growth. A rising trend indicates aggressive customer acquisition efforts, which need to be balanced against customer lifetime value.)
Stock-based compensation expense
The expense recognized for equity awards granted to employees and directors, such as stock options or restricted stock units. (This is a non-cash expense that is included in various operating cost categories. Understanding its allocation helps in analyzing the true operating performance of different segments.)
Reserve for Veterinary Invoices
An estimate of the amount of money the company expects to pay for veterinary services for claims that have been incurred but not yet paid. (This liability on the balance sheet is crucial for assessing the company's ability to meet its future payment obligations for services rendered.)

Year-Over-Year Comparison

Trupanion has demonstrated a significant turnaround in profitability, swinging from a net loss of $11.289 million in the first nine months of 2024 to a net income of $13.803 million for the same period in 2025. This improvement is accompanied by a consistent revenue growth of approximately 12% year-over-year for both the quarter and the year-to-date period. While operating expenses, particularly in technology and new pet acquisition, have increased, the company has managed to improve its operating income and net income, suggesting enhanced operational efficiency and pricing power. The balance sheet shows growth in total assets, supported by increased investments and receivables, while long-term debt has been reduced, indicating a strengthening financial position.

Filing Stats: 4,643 words · 19 min read · ~15 pages · Grade level 15.7 · Accepted 2025-11-06 17:02:53

Key Financial Figures

Filing Documents

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements (unaudited)

Item 1. Financial Statements (unaudited) 1

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 20

Quantitative and Qualitative Disclosures About Market Risk

Item 3. Quantitative and Qualitative Disclosures About Market Risk 41

Controls and Procedures

Item 4. Controls and Procedures 41

- OTHER INFORMATION

PART II - OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 42

Risk Factors

Item 1A. Risk Factors 42

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 42

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 43

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 43

Other Information

Item 5. Other Information 43

Exhibits

Item 6. Exhibits 44

Signatures

Signatures 45 Note About Forward-Looking Statements This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended ("Exchange Act"), and Section 27A of the Securities Act of 1933, as amended ("Securities Act"). All statements contained in this Quarterly Report on Form 10-Q other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans and our objectives for future operations, are forward-looking statements. The words "believe," "may," "will," "potentially," "estimate," "target," "continue," "anticipate," "intend," "could," "would," "project," "plan" and "expect," and similar expressions that convey uncertainty of future events or outcomes, are intended to identify forward-looking statements. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including, without limitation, those discussed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the Securities and Exchange Commission on February 27, 2025, in particular the risk factors discussed under the heading "Risk Factors" in Part I, Item 1A. Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. You should

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

Financial Statements

Item 1. Financial Statements TRUPANION, INC. Condensed Consolidated Statements of Operations (in thousands, except share data) (unaudited) Three Months Ended September 30, Nine Months Ended September 30, 2025 2024 2025 2024 Revenue $ 366,920 $ 327,456 $ 1,062,452 $ 948,377 Cost of revenue: Veterinary invoice expense (1) 263,127 238,814 766,157 703,485 Other cost of revenue (1) 43,739 39,263 130,311 119,017 Total cost of revenue 306,866 278,077 896,468 822,502 Operating expenses: Technology and development (1) 9,887 7,933 26,545 23,083 General and administrative (1) 18,311 16,977 58,325 46,903 New pet acquisition expense (1) 21,946 18,308 62,305 53,025 Depreciation and amortization 4,051 4,381 11,804 12,542 Total operating expenses 54,195 47,599 158,979 135,553 Loss from investment in joint venture — ( 34 ) ( 305 ) ( 184 ) Operating income (loss) 5,859 1,746 6,700 ( 9,862 ) Interest expense 2,790 3,820 9,683 11,071 Other (income), net ( 3,530 ) ( 3,538 ) ( 18,684 ) ( 9,601 ) Income (loss) before income taxes 6,599 1,464 15,701 ( 11,332 ) Income tax (benefit) expense 726 39 1,898 ( 43 ) Net income (loss) $ 5,873 $ 1,425 $ 13,803 $ ( 11,289 ) Net income (loss) per share: Basic $ 0.14 $ 0.03 $ 0.32 $ ( 0.27 ) Diluted $ 0.13 $ 0.03 $ 0.32 $ ( 0.27 ) Weighted average shares of common stock outstanding: Basic 43,076,695 42,233,903 42,849,769 42,076,998 Diluted 43,562,132 42,822,505 43,550,326 42,076,998 (1) Includes stock-based compensation expense as follows: Veterinary invoice expense $ 677 $ 847 $ 2,221 $ 2,625 Other cost of revenue 585 554 1,679 1,561 Technology and development 1,705 1,259 4,326 3,774 General and administrative 4,971 4,125 14,546 11,435 New pet acquisition expense 1,561 1,555 6,013 5,743 See accompanying notes to the condensed consolidated financial statements. 1 TRUPANION, INC. Condensed Consolidated Statements of Comprehensive Income (Loss) (in thousands) (unaudited) Three Months Ended September 30, Ni

View on Read The Filing